Blog

Nelson Dusetti

Mar 25, 2025, 11:05

Nelson Dusetti: PANCprofiler – A step forward in personalizing pancreatic cancer treatment

Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:

“A step forward in personalizing pancreatic cancer treatment!

We were honored to present our latest work at JFHODs, where we unveiled for the first time the development of PANCprofiler, an innovative transcriptomic signature based on deconvolution, designed to detect multidrug-resistant cells within pancreatic tumors.

A great achievement by Nicolas Fraunhoffer and the Marseille Pancreatic Cancer Team!”

Nelson Dusetti: PANCprofiler - A step forward in personalizing pancreatic cancer treatment

cancer Cancer Research Centre of Marseille CRCM fight against cancer Global fight against cancer JFHODs Marseille Pancreatic Cancer Team Nelson Dusetti. Nicolas Fraunhoffer OncoDaily Oncology PANCprofiler Pancreatic Cancer

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action